Evidence map›Paper›PMID 35927616›Full record

ArticleBMC neurology2022

Optimizing home-based long-term intensive care for neurological patients with neurorehabilitation outreach teams - protocol of a multicenter, parallel-group randomized controlled trial (OptiNIV-Study).

Thomas Platz, Thomas Kohlmann, Steffen Fleßa, Bernadette Einhäupl, Martha Koppelow, Lina Willacker, Hans-Jürgen Gdynia, Esther Henning, Jürgen Herzog, Friedemann Müller and 9 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMC neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 1 country.

Thomas PlatzNeurorehabilitation Research Group, Faculty of Medicine, University of Greifswald, Universitätsmedizin Greifswald, Fleischmannstrasse 44, 17475, Greifswald, Germany. thomas.platz@uni-greifswald.de.ORCID http://orcid.org/0000-0003-2629-9744
Thomas KohlmannInstitut für Community Medicine, Abt. Methoden der Community Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
Steffen FleßaLehrstuhl für Allgemeine Betriebswirtschaftslehre und Gesundheitsmanagement, University Greifswald, Greifswald, Germany.
Bernadette EinhäuplDepartment of Neurology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Martha KoppelowNeurorehabilitation Research Group, Faculty of Medicine, University of Greifswald, Universitätsmedizin Greifswald, Fleischmannstrasse 44, 17475, Greifswald, Germany.
Lina WillackerDepartment of Neurology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Hans-Jürgen Gdyniam&i-Fachklinik Enzensberg, Füssen, Germany.
Esther HenningInstitut für Community Medicine, Abt. Methoden der Community Medicine, Universitätsmedizin Greifswald, Greifswald, Germany.
Jürgen HerzogSchön Klinik München Schwabing, Munich, Germany.
Friedemann MüllerSchön Klinik Bad Aibling Harthausen, Bad Aibling, Germany.
Dennis A NowakVAMED Klinik Kipfenberg, Kipfenberg, Germany.
Romy PletzNeurorehabilitation Research Group, Faculty of Medicine, University of Greifswald, Universitätsmedizin Greifswald, Fleischmannstrasse 44, 17475, Greifswald, Germany.
Felix SchlachetzkiKlinik für Neurologie der Universität Regensburg am Medbo Bezirksklinikum, Zentrum für Vaskuläre Neurologie und Intensivmedizin, Regensburg, Germany.
Tobias Schmidt-WilckeNeurologisches Zentrum am Bezirksklinikum Mainkofen, Deggendorf, Germany.
Michael SchüttlerSchön Klinik Bad Staffelstein, Bad Staffelstein, Germany.
Andreas StraubeDepartment of Neurology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Rebekka SüssLehrstuhl für Allgemeine Betriebswirtschaftslehre und Gesundheitsmanagement, University Greifswald, Greifswald, Germany.
Volker ZieglerKlinik für Neurologische Frührehabilitation, Rhön-Klinikum, Bad Neustadt a. d. Saale, Germany.
Andreas BenderDepartment of Neurology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Universitätsmedizin Greifswald · DELudwig-Maximilians-Universität München · DESchön Klinik München Schwabing · DEHelios Klinik Kipfenberg · DERhön-Klinikum · DESchön Klinik Bad Aibling · DETherapiezentrum Burgau · DEUniversity Hospital Regensburg · DE

Funding

Innovationsausschuss beim G-BA 01NVF20027
6 · The paper itself

Abstract

backgroundEven with high standards of acute care and neurological early rehabilitation (NER) a substantial number of patients with neurological conditions still need mechanical ventilation and/or airway protection by tracheal cannulas when discharged and hence home-based specialised intensive care nursing (HSICN). It may be possible to improve the home care situation with structured specialized long-term neurorehabilitation support and following up patients with neurorehabilitation teams. Consequently, more people might recover over an extended period to a degree that they were no longer dependent on HSICN.

methodsThis healthcare project and clinical trial implements a new specialised neurorehabilitation outreach service for people being discharged from NER with the need for HSICN. The multicentre, open, parallel-group RCT compares the effects of one year post-discharge specialized outpatient follow-up to usual care in people receiving HSICN. Participants will randomly be assigned to receive the new form of healthcare (intervention) or the standard healthcare (control) on a 2:1 basis. Primary outcome is the rate of weaning from mechanical ventilation and/or decannulation (primary outcome) after one year, secondary outcomes include both clinical and economic measures. 173 participants are required to corroborate a difference of 30 vs. 10% weaning success rate statistically with 80% power at a 5% significance level allowing for 15% attrition. DISCUSSION: The OptiNIV-Study will implement a new specialised neurorehabilitation outreach service and will determine its weaning success rates, other clinical outcomes, and cost-effectiveness compared to usual care for people in need for mechanical ventilation and/or tracheal cannula and hence HSICN after discharge from NER.

trial registrationThe trial OptiNIV has been registered in the German Clinical Trials Register (DRKS) since 18.01.2022 with the ID DRKS00027326 .

Indexed as

AftercareNeurological RehabilitationCritical CareHumansMulticenter Studies as TopicPatient DischargeRandomized Controlled Trials as TopicRespiration, ArtificialClinical trialHealthcareNeurorehabilitationProtocolWeaning

Identifiers

PMID35927616
PMCPMC9351064
OpenAlexW4289745271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.